[{"address1": "500 Unicorn Park Drive", "address2": "Suite 303", "city": "Woburn", "state": "MA", "zip": "01801", "country": "United States", "phone": "781 222 9600", "website": "https://www.replimune.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Replimune Group, Inc., a clinical-stage biotechnology company, focuses on the development of oncolytic immunotherapies to treat cancer. The company's proprietary tumor-directed oncolytic immunotherapy product candidates are designed and intended to activate the immune system against cancer. Its lead product candidate is RP1, a selectively replicating version of HSV-1 that expresses GALV-GP R(-) and human GM-CSF, which is in Phase I/II clinical trials for a range of solid tumors. The company is also developing RP2, which is in Phase I clinical trials to express an anti-CTLA-4 antibody-like protein to block the inhibition of the immune response otherwise caused by CTLA-4; and RP3 that is in Phase I clinical trial to express immune-activating proteins that stimulate T cells. Replimune Group, Inc. was founded in 2015 and is headquartered in Woburn, Massachusetts.", "fullTimeEmployees": 331, "companyOfficers": [{"maxAge": 1, "name": "Mr. Philip  Astley-Sparke F.S.A.", "age": 53, "title": "Executive Chairman", "yearBorn": 1971, "fiscalYear": 2024, "totalPay": 960520, "exercisedValue": 0, "unexercisedValue": 435967}, {"maxAge": 1, "name": "Ms. Emily Luisa Hill", "age": 44, "title": "Chief Financial Officer", "yearBorn": 1980, "fiscalYear": 2024, "totalPay": 593047, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Konstantinos  Xynos M.B.A., M.D., Ph.D.", "age": 57, "title": "Chief Medical Officer", "yearBorn": 1967, "fiscalYear": 2024, "totalPay": 668686, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Sushil  Patel Ph.D.", "age": 53, "title": "CEO & Director", "yearBorn": 1971, "fiscalYear": 2024, "totalPay": 665050, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Robert  Coffin Ph.D.", "age": 59, "title": "Founder, Chief Scientist & Director", "yearBorn": 1965, "fiscalYear": 2024, "totalPay": 785888, "exercisedValue": 0, "unexercisedValue": 5822722}, {"maxAge": 1, "name": "Mr. Andrew  Schwendenman", "age": 48, "title": "Chief Accounting Officer & Treasurer", "yearBorn": 1976, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Shawn  Glidden J.D.", "title": "Senior Vice President of General Counsel", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Camilo  Garcia M.A., M.B.A.", "title": "Chief Human Resource Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Christopher  Sarchi", "age": 55, "title": "Chief Commercial Officer", "yearBorn": 1969, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Paul  Bullock", "title": "Chief Manufacturing Officer & Framingham Site Head", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 5, "boardRisk": 8, "compensationRisk": 8, "shareHolderRightsRisk": 8, "overallRisk": 8, "governanceEpochDate": 1738368000, "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 12.635, "open": 12.55, "dayLow": 11.86, "dayHigh": 12.794, "regularMarketPreviousClose": 12.635, "regularMarketOpen": 12.55, "regularMarketDayLow": 11.86, "regularMarketDayHigh": 12.794, "payoutRatio": 0.0, "beta": 1.305, "forwardPE": -4.7137547, "volume": 929402, "regularMarketVolume": 929402, "averageVolume": 739632, "averageVolume10days": 578380, "averageDailyVolume10Day": 578380, "bid": 9.16, "ask": 15.36, "bidSize": 2, "askSize": 2, "marketCap": 976547712, "fiftyTwoWeekLow": 4.92, "fiftyTwoWeekHigh": 17.0, "fiftyDayAverage": 12.7863, "twoHundredDayAverage": 10.7989, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 516049408, "profitMargins": 0.0, "floatShares": 52963065, "sharesOutstanding": 77014800, "sharesShort": 9079342, "sharesShortPriorMonth": 7261267, "sharesShortPreviousMonthDate": 1736899200, "dateShortInterest": 1739491200, "sharesPercentSharesOut": 0.1179, "heldPercentInsiders": 0.041789997, "heldPercentInstitutions": 1.0268, "shortRatio": 11.74, "shortPercentOfFloat": 0.1626, "impliedSharesOutstanding": 78469000, "bookValue": 6.264, "priceToBook": 2.0242658, "lastFiscalYearEnd": 1711843200, "nextFiscalYearEnd": 1743379200, "mostRecentQuarter": 1735603200, "netIncomeToCommon": -228242000, "trailingEps": -3.07, "forwardEps": -2.69, "enterpriseToEbitda": -2.185, "52WeekChange": 0.42286038, "SandP52WeekChange": 0.14239466, "quoteType": "EQUITY", "currentPrice": 12.68, "targetHighPrice": 31.0, "targetLowPrice": 14.0, "targetMeanPrice": 21.125, "targetMedianPrice": 20.0, "recommendationMean": 1.625, "recommendationKey": "buy", "numberOfAnalystOpinions": 8, "totalCash": 536539008, "totalCashPerShare": 6.967, "ebitda": -236204992, "totalDebt": 76041000, "quickRatio": 11.268, "currentRatio": 11.434, "debtToEquity": 15.764, "returnOnAssets": -0.26304, "returnOnEquity": -0.50501, "freeCashflow": -112702376, "operatingCashflow": -184684992, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "REPL", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "exchange": "NMS", "messageBoardId": "finmb_571664452", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "shortName": "Replimune Group, Inc.", "longName": "Replimune Group, Inc.", "earningsTimestamp": 1739365200, "earningsTimestampStart": 1747225800, "earningsTimestampEnd": 1747657800, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -3.07, "epsForward": -2.69, "epsCurrentYear": -2.81277, "priceEpsCurrentYear": -4.508012, "fiftyDayAverageChange": -0.1062994, "fiftyDayAverageChangePercent": -0.0083135385, "twoHundredDayAverageChange": 1.8811007, "twoHundredDayAverageChangePercent": 0.17419374, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "1.6 - Buy", "cryptoTradeable": false, "corporateActions": [], "postMarketTime": 1740781646, "regularMarketTime": 1740776401, "regularMarketChangePercent": 0.35615414, "regularMarketPrice": 12.68, "marketState": "CLOSED", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1532093400000, "postMarketChangePercent": -1.97161, "postMarketPrice": 12.43, "postMarketChange": -0.25, "regularMarketChange": 0.045000076, "regularMarketDayRange": "11.86 - 12.794", "fullExchangeName": "NasdaqGS", "averageDailyVolume3Month": 739632, "fiftyTwoWeekLowChange": 7.76, "fiftyTwoWeekLowChangePercent": 1.5772358, "fiftyTwoWeekRange": "4.92 - 17.0", "fiftyTwoWeekHighChange": -4.3199997, "fiftyTwoWeekHighChangePercent": -0.25411764, "fiftyTwoWeekChangePercent": 42.286037, "displayName": "Replimune", "trailingPegRatio": null, "__fetch_time": "2025-03-01"}]